已收盘 08-01 16:00:00 美东时间
-0.060
-1.99%
Bionano Genomics announced it will host a conference call and live webcast on Thursday, August 14, 2025, at 4:30 p.m. ET to discuss second quarter 2025 financial results and recent corporate progress. The event details include the date, time, participant and webcast links, and replay information available on Bionano’s investor relations website for 30 days. Contact information for the company and investor relations is also provided.
07-31 20:05
On May 24-27, 2025, Bionano Genomics participated in the European Society of Human Genetics (ESHG) conference in Milan, Italy, showcasing the utility of Optical Genome Mapping (OGM) in detecting structural variants (SVs) linked to genetic diseases. The event featured 21 studies from 12 countries, highlighting OGM's effectiveness in identifying SVs often missed by traditional methods and its potential for addressing complex genetic conditions. Ora...
06-18 12:00
Analysts are intrested in these 5 stocks: ( ($KR) ), ( ($BNGO) ), ( ($BILI) ), ...
05-24 17:01
潜在涨幅300.0%!HC Wainwright & Co.:Armata Pharmaceuticals获机构升目标价至9美元,维持"买入"评级
05-21 16:44
Maxim Group analyst Jason McCarthy upgrades Bionano Genomics (NASDAQ:BNGO) from Hold to Buy and announces $8 price target.
05-20 22:39
Cisco Systems (NASDAQ:CSCO) declares $0.41/share quarterly dividend, in line with previous. Forward yield 2.57% Payable July 23; for shareholders of record July 3; ex-div July 3. See CSCO Dividend Sco...
05-15 21:34
Bionano Genomics (NASDAQ:BNGO) lowers FY2025 sales outlook from $29.00 million-$32.00 million to $26.00 million-$30.00 million vs $33.43 million estimate.
05-15 05:22
Bionano Genomics (NASDAQ:BNGO) shares jumped in post market trading on Wednesday after it reported its first quarter revenue above expectations. The company posted first quarter revenue of $6.46M, bea...
05-15 05:02
Bionano Genomics shares are trading higher following better-than-expected Q1 re...
05-15 04:22
Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $6.50 million which beat the analyst consensus estimate of $6.23 million by 4.28 percent. This is a 25.88 percent decrease over sales of $8.77 million the same
05-15 04:02